BARDA drops funding of research into stem cells for COVID-19

Rick-Bright-BARDA

Katie Thomas at the New York Times reports that BARDA has dropped considering funding applications for stem cells for COVID-19. The move is part of a larger shift in funding priorities away from lung treatments and toward vaccine development. The decision has puzzled and even angered some stem cell firms and researchers. BARDA stands for …

BARDA drops funding of research into stem cells for COVID-19 Read More »